SEMAGLUTIDE AND TIRZEPATIDE IN TYPE 2 DIABETES: PATIENT CHARACTERISTICS AND WEIGHT-RELATED OUTCOMES IN THE REAL-WORLD SETTING

被引：0
|
作者：
Althoff, A. [1 ]
Rasouliyan, L. [1 ]
机构：
[1] OMNY Hlth, Atlanta, GA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD104
引用
收藏
页码：S238 / S239
页数：2
相关论文
共 50 条
  • [31] Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis
    Azuri, Joseph
    Hammerman, Ariel
    Aboalhasan, Enis
    Ben Sluckis
    Arbel, Ronen
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 961 - 964
  • [32] Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach
    Hamdy, Osama
    Ashrafzadeh, Sahar
    Mottalib, Adham
    CURRENT DIABETES REPORTS, 2018, 18 (09)
  • [33] Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach
    Osama Hamdy
    Sahar Ashrafzadeh
    Adham Mottalib
    Current Diabetes Reports, 2018, 18
  • [34] Incidence of stroke and related outcomes in people with type 2 diabetes: a real-world database study in France
    Mohammedi, K.
    Sibon, I.
    Fauchier, L.
    Quignot, N.
    Khachatryan, A.
    Banon, T.
    Kapnang, R.
    Kikuchi, K.
    Ren, H.
    Massien, C.
    Vigie, L.
    Larsen, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S497 - S497
  • [35] Semaglutide once weekly in people with type 2 diabetes: Real-world analysis of the CanadianLMCdiabetes registry (SPAREstudy)
    Brown, Ruth E.
    Bech, Peter G.
    Aronson, Ronnie
    DIABETES OBESITY & METABOLISM, 2020, 22 (11): : 2013 - 2020
  • [36] Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
    Patti, Angelo Maria
    Giglio, Rosaria Vincenza
    Allotta, Alberto
    Bruno, Andreina
    Di Bella, Tommaso
    Stoian, Anca Pantea
    Ciaccio, Marcello
    Rizzo, Manfredi
    BIOMEDICINES, 2023, 11 (05)
  • [37] PIONEER REAL Italy: Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes
    Manti, Roberta
    De Cosmo, Salvatore
    Desenzani, Paolo
    Ferrara, Lidia
    Girelli, Angela
    Memoli, Giuseppe
    Bisio, Alessandro
    Braae, Uffe Christian
    Deinega, Alisa
    Berra, Cesare
    PIONEER REAL Italy Investigators, Massimiliano
    DIABETES THERAPY, 2025, : 1019 - 1032
  • [38] Glycaemic and weight-loss outcomes of graded doses of canagliflozin in type 2 diabetes - a real-world study
    Dutta, Deep
    Sharma, Meha
    Dhall, Anil
    Aggarwal, Sameer
    Khandelwal, Deepak
    CLINICAL DIABETOLOGY, 2020, 9 (06): : 442 - 453
  • [39] Predictors of Glycemic and Weight Response to Exenatide Once-Weekly in Patients with Type 2 Diabetes in a Real-World Setting
    Gorgojo-Martinez, Juan J.
    Brito-Sanfiel, Miguel A.
    Gargallo-Fernandez, Manuel A.
    Lisbona-Catalan, Arturo
    DIABETES, 2017, 66 : A297 - A297
  • [40] Real-world experience of adjunct weekly semaglutide in Type 1 diabetes. Is it worth it?
    Cohen, Neale
    Yeung, Asher
    Jenkins, Alicia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 219
12345